Western blot analysis of E-cadherin and vimentin in tumor lysates (Figure 2H) and E-cadherin immunohistochemical staining of the tumors (Figure S4B) confirmed that the EMT status was retained in tumors formed by miR-100-expressing HMLE-Erbb2 cells. The gene discussed is VIM; the disease is neoplasm.